Clinical Trial Update: Duration of Ameluz Application in Acral Actinic Keratoses Response [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update notes the termination of a study evaluating the optimal duration of Ameluz application for acral actinic keratoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

Sponsor: Royal Cornwall Hospitals Trust | Conditions: Actinic Keratoses, Photodamaged Skin | Phase 4 | Status: TERMINATED